Strong proband and family phenotypic presentations, and biallelic inactivation of TP53 are consisted with Li-Fraumeni syndrome.  MMR-P/MSS and intact IHC rule out Lynch-related colon cancer. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.